An Open-Label, Single-Period, Two-Stage, Single Oral Dose Pharmacokinetic Study of Remogliflozin Etabonate Tablet 100 and 250 mg in Healthy Asian Indian Male Subjects Under Fasting and Fed Conditions.

Saved in:
Bibliographic Details
Title: An Open-Label, Single-Period, Two-Stage, Single Oral Dose Pharmacokinetic Study of Remogliflozin Etabonate Tablet 100 and 250 mg in Healthy Asian Indian Male Subjects Under Fasting and Fed Conditions.
Authors: Joshi S; Joshi Clinic, Lilavati Hospital, Apollo Sugar Clinic and Bhatia Hospital, Mumbai, India., Gudi G; Drug Metabolism and Pharmacokinetics, Glenmark Pharmaceuticals Inc, Paramus, NJ, USA., Menon VCA; Drug Metabolism and Pharmacokinetics, Glenmark Pharmaceuticals Ltd, Mumbai, India., Tandon M; Clinical Development, Glenmark Pharmaceuticals Ltd, Mumbai, India., Joshi V; Clinical Research, Glenmark Pharmaceuticals Ltd, Mumbai, India., Suryawanshi S; Medical Services, Glenmark Pharmaceuticals Ltd, Mumbai, India., Barkate H; Medical Services, Glenmark Pharmaceuticals Ltd, Mumbai, India., Sawant N; Clinical Research, Glenmark Pharmaceuticals Ltd, Mumbai, India., Katare S; Medical Services, Glenmark Pharmaceuticals Ltd, Mumbai, India. sagar.katare@glenmarkpharma.com., Siddique W; Medical Services, Glenmark Pharmaceuticals Ltd, Mumbai, India.
Source: Clinical pharmacokinetics [Clin Pharmacokinet] 2020 Mar; Vol. 59 (3), pp. 349-357.
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Adis, part of Springer Science+Business Media Country of Publication: Switzerland NLM ID: 7606849 Publication Model: Print Cited Medium: Internet ISSN: 1179-1926 (Electronic) Linking ISSN: 03125963 NLM ISO Abbreviation: Clin Pharmacokinet Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1179-1926
DOI:10.1007/s40262-019-00819-4